On February 25, 2022, Johnson & Johnson and three major drug distributors—McKesson, Cardinal Health, and AmerisourceBergen—finalized a $26 billion national settlement to resolve thousands of opioid lawsuits from states, counties, cities, and Native American tribes. Despite the record settlement …
On August 26, 2019, Cleveland County District Judge Thad Balkman delivered a landmark $572 million judgment against pharmaceutical giant Johnson & Johnson for the company’s role in fueling Oklahoma’s opioid epidemic. The decision marked the first time a drugmaker was held culpable in …
Thad BalkmanJohnson & JohnsonState of Oklahomaopioid-crisislegal-accountabilitypublic-nuisancecorporate-liabilitystate-lawsuits
Johns Hopkins researchers published findings demonstrating that pharmaceutical companies were systematically gaming the 1983 Orphan Drug Act by obtaining orphan drug designations—intended for treatments of rare diseases affecting fewer than 200,000 Americans—for blockbuster drugs generating billions …
Johns Hopkins UniversityFDAAbbVieRocheJohnson & Johnson+4 morepharmaceutical-industryregulatory-capturetax-avoidancedrug-pricinghealthcare+2 more
On December 5, 2012, Elizabeth “Liz” Fowler announced her departure from the White House to join Johnson & Johnson as head of global health policy, completing her third spin through the healthcare industry revolving door. Fowler had served as the chief architect of the Affordable …
Elizabeth FowlerJohnson & JohnsonWellPointMax BaucusBarack Obama+1 morerevolving-doorregulatory-capturehealthcarelobbyingpharmaceutical-industry+3 more